Accueil>>Signaling Pathways>> TGF-β / Smad Signaling>> PKC>>DCPLA-ME

DCPLA-ME (Synonyms: DCPLA methyl ester)

Catalog No.GC38388

Le DCPLA-ME, la forme ester méthylique du DCPLA, est un puissant activateur de PKCε utilisé dans le traitement des maladies neurodégénératives.

Products are for research use only. Not for human use. We do not sell to patients.

DCPLA-ME Chemical Structure

Cas No.: 56687-67-3

Taille Prix Stock Qté
10mM (in 1mL DMSO)
393,00 $US
En stock
5mg
357,00 $US
En stock
10mg
561,00 $US
En stock
50mg
1 683,00 $US
En stock
100mg
2 295,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

DCPLA-ME, the methyl ester form of DCPLA, is a potent PKCε activator for use in the treatment of neurodegenerative diseases[1].

[1]. Thomas J. Nelson, et al. Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases. WO2015058191A1.

Avis

Review for DCPLA-ME

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for DCPLA-ME

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.